Sphingosine-1-phosphate (S1P) is a bioactive lipid that promotes cell survival, proliferation and migration, platelet aggregation, mediates ischemic preconditioning, and is essential for angiogenesis and lymphocyte trafficking. Sphingosine-1-phosphate lyase (SPL) is the enzyme responsible for the irreversible degradation of S1P and is, thus, in a strategic position to regulate these same processes by removing available S1P signaling pools, that is, silencing the siren. In fact, recent studies have implicated SPL in the regulation of immunity, cancer surveillance and other physiological processes. Here, we summarize the current understanding of SPL function and regulation, and discuss how SPL might facilitate cancer chemoprevention and serve as a target for modulation of immune responses in transplantation settings and in the treatment of autoimmune disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.molmed.2007.03.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical presentation and management challenges of sphingosine-1-phosphate lyase insufficiency syndrome associated with an SGPL1 variant: a case report.
BMC Pediatr
January 2025
Geriatric Mental Health Research Center, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Background: This case report describes a unique presentation of sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) caused by a rare SGPL1 variant, highlighting the diagnostic and management challenges associated with this condition.
Case Presentation: A 2-year-old Iranian female presented with steroid-resistant nephrotic syndrome (NS), primary adrenal insufficiency (AI), growth delay, seizures, and hyperpigmentation. Laboratory evaluation revealed hypoalbuminemia, significant proteinuria, hyperkalemia, and elevated adrenocorticotropic hormone (ACTH) levels.
Urothelial Urinary Bladder Cancer Is Characterized by Stage-Dependent Aberrations in Metabolism of Bioactive Sphingolipids.
Int J Mol Sci
November 2024
Department of Physiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Białystok, Poland.
Article Synopsis
- This study investigates the metabolism of bioactive sphingolipids in bladder cancer, focusing on differences between non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) tumors in 48 patients.
- Results showed that MIBC tumors had increased levels of sphingosine-1-phosphate (S1P) and ceramide compared to healthy tissue and NMIBC tumors, indicating stage-dependent changes in sphingolipid metabolism.
- The researchers suggest that the dysregulation of S1P metabolism may play a role in the progression of urothelial bladder cancer as it transitions from NMIBC to MIBC.
Sphingosine phosphate lyase insufficiency syndrome as a primary immunodeficiency state.
Adv Biol Regul
December 2024
Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. Electronic address:
Sphingosine phosphate lyase insufficiency syndrome (SPLIS) is a genetic disease associated with renal, endocrine, neurological, skin and immune defects. SPLIS is caused by inactivating mutations in SGPL1, which encodes sphingosine phosphate lyase (SPL). SPL catalyzes the irreversible degradation of the bioactive sphingolipid sphingosine-1-phosphate (S1P), a key regulator of lymphocyte egress.
View Article and Find Full Text PDFA role for plasma membrane Ca ATPases in regulation of cellular Ca homeostasis by sphingosine kinase-1.
Pflugers Arch
December 2024
Institut Für Allgemeine Pharmakologie Und Toxikologie, Goethe-Universität Frankfurt, Universitätsklinikum, Frankfurt am Main, Germany.
Sphingosine-1-phosphate (S1P) is a ubiquitous lipid mediator, acting via specific G-protein-coupled receptors (GPCR) and intracellularly. Previous work has shown that deletion of S1P lyase caused a chronic elevation of cytosolic [Ca] and enhanced Ca storage in mouse embryonic fibroblasts. Here, we studied the role of sphingosine kinase (SphK)-1 in Ca signaling, using two independently generated EA.
View Article and Find Full Text PDFFactors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients.
Orphanet J Rare Dis
September 2024
Department of Pediatrics, University of California, San Francisco, CA, USA.
Article Synopsis
- Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) is a rare genetic disorder linked to severe health issues like nephrotic syndrome, adrenal insufficiency, and various systemic symptoms, primarily caused by mutations in the SGPL1 gene.
- A study of 76 SPLIS patients found that overall survival is around 50%, with survival influenced by factors such as age at diagnosis, organ involvement, whether the patient received a kidney transplant, and specific SGPL1 genotypes.
- Children diagnosed with SPLIS nephropathy before age one have a significantly worse survival rate compared to those diagnosed after one year, highlighting the importance of early diagnosis and potential interventions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!